We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+8.61%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.42B
AUM Growth
-$3.38B
(-38%)
Cap. Flow
-$3.75B
Cap. Flow
% of AUM
-69.25%
Top 10 Holdings %
Top 10 Hldgs %
40.63%
Holding
1,042
New
84
Increased
109
Reduced
414
Closed
284
Avg Time Held Equity + Options
3.7
quarters
Top 10 Avg Time Held Equity + Options
0.5
quarters
Top 20 Avg Time Held Equity + Options
0.8
quarters
Avg Time Held Equity only
3.7
quarters
Top 10 Avg Time Held Equity only
0.5
quarters
Top 20 Avg Time Held Equity only
0.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$184M |
| 2 |
STOR
STORE Capital Corporation
STOR
|
+$172M |
| 3 |
First Horizon
FHN
|
+$107M |
| 4 |
COUP
Coupa Software Incorporated
COUP
|
+$96.9M |
| 5 |
AAWW
Atlas Air Worldwide Holdings, Inc.
AAWW
|
+$64.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$572M |
| 2 |
ZEN
ZENDESK INC
ZEN
|
+$456M |
| 3 |
AVLR
Avalara, Inc.
AVLR
|
+$373M |
| 4 |
SWCH
Switch, Inc. Class A Common Stock
SWCH
|
+$271M |
| 5 |
Rogers Corp
ROG
|
+$219M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 25.7% |
| 2 | Technology | 18.31% |
| 3 | Healthcare | 15.11% |
| 4 | Miscellaneous | 11.75% |
| 5 | Real Estate | 10.91% |
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q4 2022 Portfolio in Review
As of Q4 2022, UBS O'Connor held 1,042 positions worth $5.42B, down 38% from $8.8B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
UBS O'Connor withdrew a net $3.75B in Q4 2022, closing 284 positions and reducing 414 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.
By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.
Against the trend, UBS O'Connor opened a new position in Coupa Software Incorporated worth $128M.
- UBS O'Connor's largest Q4 2022 buy was Coupa Software Incorporated: 1,619,333 shares worth $128M.
- UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
- UBS O'Connor's biggest Q4 2022 reduction was Rogers Corp, cutting an estimated $219M.
- UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
- UBS O'Connor's ten largest holdings make up 41% of its $5.42B portfolio in Q4 2022.
- UBS O'Connor opened 84 new positions and closed 284 in Q4 2022.
- UBS O'Connor's portfolio value fell 38% quarter-over-quarter to $5.42B.
Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.